Exact Mass: 606.4549

Exact Mass Matches: 606.4549

Found 192 metabolites which its exact mass value is equals to given mass value 606.4549, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Staphidine

CID 441760

C42H58N2O (606.4549)

FAHFA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/9-O-18:2(10E,12Z))

(10E,12Z)-9-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]octadeca-10,12-dienoic acid

C40H62O4 (606.4648)

Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/9-O-18:2(10E,12Z)), in particular, is formed from the condensation of the carboxy group of docosahexaenoic acid (DHA) with the hydroxy group of 9-hydroxyoctadecadienoic acid. It is alternatively named 9-DHAHLA since it is the 9-hydroxy isomer of the DHAHLA (docosahexaenoic acid-hydroxylinoleic acid) family.

FAHFA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/13-O-18:2(9Z,11E))

(9Z,11E)-13-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]octadeca-9,11-dienoic acid

C40H62O4 (606.4648)

Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/13-O-18:2(9Z,11E)), in particular, is formed from the condensation of the carboxy group of docosahexaenoic acid (DHA) with the hydroxy group of 13-hydroxyoctadecadienoic acid. It is alternatively named 13-DHAHLA since it is the 13-hydroxy isomer of the DHAHLA (docosahexaenoic acid-hydroxylinoleic acid) family.

Tasidotin

N-Tert-butyl-1-{1-[2-(2-{[2-(dimethylamino)-1-hydroxy-3-methylbutylidene]amino}-N,3-dimethylbutanamido)-3-methylbutanoyl]pyrrolidine-2-carbonyl}pyrrolidine-2-carboximidate

C32H58N6O5 (606.4468)

DG(13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/13:0/0:0)

(2S)-3-hydroxy-2-(tridecanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C36H62O7 (606.4495)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-hydroxy-3-(tridecanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C36H62O7 (606.4495)

DG(13:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(13:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(13:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(a-13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(a-13:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C36H62O7 (606.4495)

DG(a-13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C36H62O7 (606.4495)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(a-13:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(a-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(a-13:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(i-13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(i-13:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C36H62O7 (606.4495)

DG(i-13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C36H62O7 (606.4495)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C36H62O7 (606.4495)

DG(i-13:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C36H62O7 (606.4495)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(i-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(i-13:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C36H62O7 (606.4495)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Irpexan

C36H62O7 (606.4495)

PA(O-16:0/14:0)

1-hexadecyl-2-tetradecanoyl-glycero-3-phosphate

C33H67O7P (606.4624)

PA(O-18:0/12:0)

1-octadecyl-2-dodecanoyl-glycero-3-phosphate

C33H67O7P (606.4624)

FAHFA 40:8;O

(10E,12Z)-9-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyloxy)octadecadienoic acid

C40H62O4 (606.4648)

PA O-30:0

1-hexadecyl-2-tetradecanoyl-glycero-3-phosphate

C33H67O7P (606.4624)

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

Fahfa 20:5/20:3

C40H62O4 (606.4648)

Fahfa 18:5/22:3

C40H62O4 (606.4648)

Fahfa 22:6/18:2

C40H62O4 (606.4648)

Fahfa 16:4/24:4

C40H62O4 (606.4648)

Fahfa 18:3/22:5

C40H62O4 (606.4648)

Fahfa 18:4/22:4

C40H62O4 (606.4648)

Fahfa 20:4/20:4

C40H62O4 (606.4648)

Fahfa 22:5/18:3

C40H62O4 (606.4648)

2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[2-hexanoyloxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[3-[(Z)-hexadec-9-enoxy]-2-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[hydroxy-[2-hydroxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[2-decanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-octoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[hydroxy-[3-[(Z)-tridec-9-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[3-[(Z)-henicos-11-enoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[hydroxy-[3-nonoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[hydroxy-[2-[(Z)-tridec-9-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[3-decoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[3-[(Z)-heptadec-9-enoxy]-2-heptanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[2-acetyloxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[[2-butanoyloxy-3-[(Z)-icos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[hydroxy-[3-[(Z)-nonadec-9-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

2-[hydroxy-[2-nonanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO7P+ (606.4498)

CID 441760

C42H58N2O (606.4549)

1-hexadecyl-2-tetradecanoyl-glycero-3-phosphate

C33H67O7P (606.4624)

OAHFA(40:8)

OAHFA(20:4_20:4)

C40H62O4 (606.4648)

BisMePA(28:0)

BisMePA(12:0(1)_16:0)

C33H67O7P (606.4624)

FAHFA 14:1/O-26:7

C40H62O4 (606.4648)

FAHFA 14:2/O-26:6

C40H62O4 (606.4648)

FAHFA 14:3/O-26:5

C40H62O4 (606.4648)

FAHFA 14:4/O-26:4

C40H62O4 (606.4648)

FAHFA 15:1/O-25:7

C40H62O4 (606.4648)

FAHFA 15:2/O-25:6

C40H62O4 (606.4648)

FAHFA 15:3/O-25:5

C40H62O4 (606.4648)

FAHFA 15:4/O-25:4

C40H62O4 (606.4648)

FAHFA 15:5/O-25:3

C40H62O4 (606.4648)

FAHFA 16:1/O-24:7

C40H62O4 (606.4648)

FAHFA 16:2/O-24:6

C40H62O4 (606.4648)

FAHFA 16:3/O-24:5

C40H62O4 (606.4648)

FAHFA 16:4/O-24:4

C40H62O4 (606.4648)

FAHFA 16:5/O-24:3

C40H62O4 (606.4648)

FAHFA 17:1/O-23:7

C40H62O4 (606.4648)

FAHFA 17:2/O-23:6

C40H62O4 (606.4648)

FAHFA 17:3/O-23:5

C40H62O4 (606.4648)

FAHFA 17:4/O-23:4

C40H62O4 (606.4648)

FAHFA 17:5/O-23:3

C40H62O4 (606.4648)

FAHFA 18:1/O-22:7

C40H62O4 (606.4648)

FAHFA 18:2/O-22:6

C40H62O4 (606.4648)

FAHFA 18:3/O-22:5

C40H62O4 (606.4648)

FAHFA 18:4/O-22:4

C40H62O4 (606.4648)

FAHFA 18:5/O-22:3

C40H62O4 (606.4648)

FAHFA 18:6/O-22:2

C40H62O4 (606.4648)

FAHFA 19:1/O-21:7

C40H62O4 (606.4648)

FAHFA 19:2/O-21:6

C40H62O4 (606.4648)

FAHFA 19:3/O-21:5

C40H62O4 (606.4648)

FAHFA 19:4/O-21:4

C40H62O4 (606.4648)

FAHFA 19:5/O-21:3

C40H62O4 (606.4648)

FAHFA 19:6/O-21:2

C40H62O4 (606.4648)

FAHFA 20:2/O-20:6

C40H62O4 (606.4648)

FAHFA 20:3/O-20:5

C40H62O4 (606.4648)

FAHFA 20:4/O-20:4

C40H62O4 (606.4648)

FAHFA 20:5/O-20:3

C40H62O4 (606.4648)

FAHFA 20:6/O-20:2

C40H62O4 (606.4648)

FAHFA 21:2/O-19:6

C40H62O4 (606.4648)

FAHFA 21:3/O-19:5

C40H62O4 (606.4648)

FAHFA 21:4/O-19:4

C40H62O4 (606.4648)

FAHFA 21:5/O-19:3

C40H62O4 (606.4648)

FAHFA 21:6/O-19:2

C40H62O4 (606.4648)

FAHFA 21:7/O-19:1

C40H62O4 (606.4648)

FAHFA 22:2/O-18:6

C40H62O4 (606.4648)

FAHFA 22:3/O-18:5

C40H62O4 (606.4648)

FAHFA 22:4/O-18:4

C40H62O4 (606.4648)

FAHFA 22:5/O-18:3

C40H62O4 (606.4648)

FAHFA 22:6/O-18:2

C40H62O4 (606.4648)

FAHFA 22:7/O-18:1

C40H62O4 (606.4648)

FAHFA 23:3/O-17:5

C40H62O4 (606.4648)

FAHFA 23:4/O-17:4

C40H62O4 (606.4648)

FAHFA 23:5/O-17:3

C40H62O4 (606.4648)

FAHFA 23:6/O-17:2

C40H62O4 (606.4648)

FAHFA 23:7/O-17:1

C40H62O4 (606.4648)

FAHFA 24:3/O-16:5

C40H62O4 (606.4648)

FAHFA 24:4/O-16:4

C40H62O4 (606.4648)

FAHFA 24:5/O-16:3

C40H62O4 (606.4648)

FAHFA 24:6/O-16:2

C40H62O4 (606.4648)

FAHFA 24:7/O-16:1

C40H62O4 (606.4648)

FAHFA 25:3/O-15:5

C40H62O4 (606.4648)

FAHFA 25:4/O-15:4

C40H62O4 (606.4648)

FAHFA 25:5/O-15:3

C40H62O4 (606.4648)

FAHFA 25:6/O-15:2

C40H62O4 (606.4648)

FAHFA 25:7/O-15:1

C40H62O4 (606.4648)

FAHFA 26:4/O-14:4

C40H62O4 (606.4648)

FAHFA 26:5/O-14:3

C40H62O4 (606.4648)

FAHFA 26:6/O-14:2

C40H62O4 (606.4648)

FAHFA 26:7/O-14:1

C40H62O4 (606.4648)

LPA 30:0

C33H67O7P (606.4624)

PA O-14:0/16:0

C33H67O7P (606.4624)

PA O-16:0/14:0

C33H67O7P (606.4624)

PA O-18:0/12:0

C33H67O7P (606.4624)

PA O-20:0/10:0

C33H67O7P (606.4624)

LPEth 28:0

C33H67O7P (606.4624)

LPM 29:0

C33H67O7P (606.4624)

annonebinide b

C40H62O4 (606.4648)

{"Ingredient_id": "HBIN016225","Ingredient_name": "annonebinide b","Alias": "NA","Ingredient_formula": "C40H62O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1318","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(5r)-5-[(11r)-11-hydroxy-11-[(2r,5r)-5-[(1r,4z)-1-hydroxytetradec-4-en-1-yl]oxolan-2-yl]-5-oxoundecyl]-3-(2-oxopropyl)oxolan-2-one

C36H62O7 (606.4495)

(5r)-5-[(11r)-11-hydroxy-11-[(2r,5r)-5-[(1r)-1-hydroxytetradec-4-en-1-yl]oxolan-2-yl]-5-oxoundecyl]-3-(2-oxopropyl)oxolan-2-one

C36H62O7 (606.4495)

5,5',7,7'-tetramethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),12-diene

5,5',7,7'-tetramethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),12-diene

C42H58N2O (606.4549)

(2s,3s,4s,5s,6r)-2-{[(6e,14e,18e)-10-hydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,6,14,18,22-pentaen-11-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O7 (606.4495)

(2r,3s,4r,5r,6r)-2-{[(6e,10s,11r,14e,18e)-10-hydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,6,14,18,22-pentaen-11-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O7 (606.4495)

2-[(10-hydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,6,14,18,22-pentaen-11-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O7 (606.4495)